{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:13:51Z","timestamp":1782252831924,"version":"3.54.5"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Turner Syndrome (TS) is the commonest chromosomal abnormality in females. Establishing and maintaining long-term follow-up after transition to adult endocrine services, to allow for essential lifelong surveillance of hypertension and cardiovascular disease, and optimal hormone replacement, remains a challenge. A TS transition clinic was established with the aim of supporting successful transfer and establishing long-term follow-up in adult endocrine services. Our objectives are to evaluate the success of our TS transition service primarily in achieving and maintaining follow-up after transfer to adult services and to assess the adequacy of health surveillance post-transition with a specific focus on cardiac monitoring and hormone replacement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A departmental database was used to identify young people whose care had transferred to adult endocrine services. An electronic case record was utilised to obtain clinic attendance and relevant clinical information on cardiovascular monitoring and hormone replacement therapy (HRT). <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Forty-six (n=46) young people transferred to adult endocrine services during the observed 20-year period, 1998-2017. Thirty-six (n=36) had transferred prior to 2015, of whom sixteen (n=16, 44%) are lost to long-term follow-up at 5 years. Overall, 41 (89%) patients have had cardiac imaging surveillance since transferring, However, only 30 (73%) of these were carried out at the recommended frequencies. All 20 women in established follow-up have had cardiac imaging. Five out of the 46 (11%) patients do not have any documented cardiovascular monitoring. Forty (86.9%) women have had a documented BP measurement. Nineteen of the 20 women who are in 5- year established follow-up have a documented blood pressure. Five (11%) women are not on HRT, while two (4%) remain on oestrogen-only HRT. Thirty-seven (80.4%) women are on combined HRT, only eight (21.6%) are on the recommended form of oestradiol. Two (4%) are not on HRT due to normal ovarian function. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>A significant proportion of girls with TS are currently lost to adult endocrine services. Strategies to improve long-term endocrine follow-up are needed to ensure lifelong health needs and adequate hormone replacement are met. Whilst similar parameters are monitored in adult endocrine services a group of patients may be at risk of receiving inadequate HRT and developing cardiovascular complications. <\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1233723","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:41:05Z","timestamp":1693554065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Turner syndrome transition clinic in the West of Scotland: a perspective"],"prefix":"10.3389","volume":"14","author":[{"given":"Baryab","family":"Zahra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Sastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Freel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avril","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"B1","volume-title":"Turner Syndrome","author":"Shankar Kikkeri","year":"2020"},{"key":"B2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0430","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting","volume":"177","author":"Gravholt","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12029","article-title":"Turner syndrome","volume":"73","author":"Freel","year":"2019","journal-title":"Hypertension"},{"key":"B4","volume-title":"Turner Syndrome Complications","year":"2009"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2020-0242","article-title":"Evaluating transition in Turner syndrome in the West of Scotland","volume":"34","author":"Zahra","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.acvd.2008.05.007","article-title":"Cardiovascular abnorMalities in Turner\u2019s syndrome: What prevention","volume":"101","author":"Dulac","year":"2008","journal-title":"Arch Cardiovasc Diseases"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3397196","article-title":"Sex hormone replacement therapy in turner syndrome: impact on morbidity and mortality","volume":"105","author":"Viuff","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2016-311372","article-title":"Hormone supplementation for pubertal induction in girls","volume":"102","author":"Matthews","year":"2017","journal-title":"Arch Dis Childhood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2019.04.056","article-title":"Near adult height in girls with turner syndrome treated with growth hormone following either induced or spontaneous puberty","author":"Lanes","year":"2019","journal-title":"J Paediatrics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-1049","article-title":"Mortality in women with turner syndrome in Great Britain: A national cohort study","author":"Mj","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1530\/endoabs.85.P23","article-title":"The prevalence of hypertension in paediatric Turner syndrome: a systematic review and meta-analysis","author":"McCarrison","year":"2022","journal-title":"J Hum Hypertension"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.17294\/2330-0698.1406","article-title":"Health care transitions for adolescents and young adults with special health care needs: where are we now","volume":"4","author":"Mubanga","year":"2017","journal-title":"J Patient-Centered Res Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.21037\/pm.2019.06.10","article-title":"Gonadal dysgenesis: a clinical overview of Turner syndrome","volume":"2","author":"Clemente","year":"2019","journal-title":"Pediatr Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(97)70137-9","article-title":"Pelvic ultrasonography in patients with Turner syndrome: Age-related findings in different karyotypes","volume":"131","author":"Mazzanti","year":"1997","journal-title":"J Pediatrics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1055\/s-0029-1242998","article-title":"Role of progesterone in endometrial cancer","volume":"28","author":"Kim","year":"2010","journal-title":"Semin Reprod Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-18-0238","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: Transition of care for young adult patients with Turner syndrome","volume":"180","author":"Bernard","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1136\/adc.2006.103804","article-title":"Transition of care from paediatric to adult services in haematology","volume":"92","author":"Bolton-Maggs","year":"2007","journal-title":"Arch Dis Childhood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03467.x\/full","article-title":"Transition process of patients with type 1 diabetes (T1DM) from paediatric to the adult health care service: a hospital-based approach","volume":"71","author":"Cadario","year":"2009","journal-title":"Clin Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1233723\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:41:10Z","timestamp":1693554070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1233723\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":18,"alternative-id":["10.3389\/fendo.2023.1233723"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1233723","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"article-number":"1233723"}}